Related Experiment Video

Updated: Apr 11, 2026

In Vitro ELISA Test to Evaluate Rabies Vaccine Potency
09:04

In Vitro ELISA Test to Evaluate Rabies Vaccine Potency

Published on: May 11, 2020

13.5K

Validation of alternative methods for the potency testing of vaccines

C Hendriksen1, J M Spieser2, A Akkermans1

  • 1National Institute of Public Health and the Environment - RIVM, 3720 BA Bilthoven, The Netherlands.

Alternatives to Laboratory Animals : ATLA
|June 5, 2015
PubMed
Abstract

No abstract available in PubMed .

More Related Videos

Alternative In Vitro Methods for the Determination of Viral Capsid Structural Integrity
12:57

Alternative In Vitro Methods for the Determination of Viral Capsid Structural Integrity

Published on: November 16, 2017

8.8K
Author Spotlight: Optimizing CFU Determination for Efficient Assessment of TB Vaccine Efficacy and Antigen Presentation Analysis
06:26

Author Spotlight: Optimizing CFU Determination for Efficient Assessment of TB Vaccine Efficacy and Antigen Presentation Analysis

Published on: July 28, 2023

3.3K

Related Experiment Videos

Last Updated: Apr 11, 2026

In Vitro ELISA Test to Evaluate Rabies Vaccine Potency
09:04

In Vitro ELISA Test to Evaluate Rabies Vaccine Potency

Published on: May 11, 2020

13.5K
Alternative In Vitro Methods for the Determination of Viral Capsid Structural Integrity
12:57

Alternative In Vitro Methods for the Determination of Viral Capsid Structural Integrity

Published on: November 16, 2017

8.8K
Author Spotlight: Optimizing CFU Determination for Efficient Assessment of TB Vaccine Efficacy and Antigen Presentation Analysis
06:26

Author Spotlight: Optimizing CFU Determination for Efficient Assessment of TB Vaccine Efficacy and Antigen Presentation Analysis

Published on: July 28, 2023

3.3K

Related Concept Videos

Vaccine Production01:23

Vaccine Production

75
Vaccine production involves a sequence of upstream and downstream processes to generate a safe and effective immunological product. It begins with cultivating microorganisms, such as viruses or bacteria, to obtain antigenic material. For viral vaccines, mammalian host cells are grown in bioreactors and subsequently infected with the target virus. The virus replicates within the host cells, which are lysed to release viral particles. This lysate is then clarified through filtration or...
75

Articles linked to this work by shared authors, journal, and citation graph.

Impact of risk and lifestyle factors on therapy goals in the treatment of breast cancer and gynecological cancer patients with integrative medicine.

Archives of gynecology and obstetrics·2025

Light Conversion by Electrochemiluminescence at Semiconductor Surfaces.

Accounts of chemical research·2024

Genetic determinants of micronucleus formation in vivo.

Nature·2024

Assay discrepancies using human coagulation factor VIII chromogenic kits: Results from a plasma-derived factor VIII collaborative study (BSP112).

Pharmeuropa bio & scientific notes·2023

Peripapillary and optic nerve head vessel density of glaucoma and healthy subjects from Afro-Caribbean and European descent: A pilot study.

Journal francais d'ophtalmologie·2022

Collaborative study for the validation of cell line assays for in-process toxicity and antigenicity testing of Clostridium septicum vaccine antigens - Part 2: Optimisation of cell line assays.

Pharmeuropa bio & scientific notes·2021

Key challenges for in vitro testing of oral tobacco and nicotine products for regulatory applications: Recommendations for using in vitro toxicity and disease models.

Alternatives to laboratory animals : ATLA·2026

Beyond rodents: A systematic review of antidepressant-like effects in Drosophila melanogaster as an alternative model in psychopharmacology.

Alternatives to laboratory animals : ATLA·2026

Frustra laborare? Methodological inefficiencies and epistemic limits in toxicological testing.

Alternatives to laboratory animals : ATLA·2026

Advancing New Approach Methodologies (NAMs) through the publication of negative results.

Alternatives to laboratory animals : ATLA·2026

Galleria mellonella as an invertebrate screening model for biocompatibility and in vivo functionality testing of imaging contrast agents.

Alternatives to laboratory animals : ATLA·2026

Data-driven science, ethics and risk: Building knowledge of key ethics-risk intersections relevant to public sector decision-making.

Alternatives to laboratory animals : ATLA·2026

Polymeric nanoparticle platforms for ibrutinib delivery: tackling solubility, CYP3A4-mediated metabolism, and resistance to facilitate BTK-targeted therapy in solid tumours.

Therapeutic delivery·2026

Propofol for depression: mechanisms and therapeutic potential.

Frontiers in physiology·2026

Plasma and breast milk pharmacokinetics of suvorexant in healthy lactating women.

British journal of clinical pharmacology·2026

Provider Preferences on Existing and Potential Future Biomedical HIV Prevention Products: A Qualitative Study in the United States, Thailand, and South Africa.

AIDS research and human retroviruses·2026

A microenvironment-responsive microsphere-PLGA-PEG-PLGA hydrogel for sustained and coordinated co-delivery of celecoxib and ropivacaine in osteoarthritis therapy.

Drug delivery and translational research·2026

Complex enzymolysis-derived peanut peptides: in silico selection of antioxidant peptides, emulsion-microcapsule encapsulation, and in vitro digestive performance evaluation.

Food research international (Ottawa, Ont.)·2026
See all related articles
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies
Jove
Visualize
Contact Us